Skip to main content
SpringerLink
Log in

Stereotactic Radiosurgery for Early Stage Non-Small Cell Lung Cancer: Rationale, Patient Selection, Results and Complications

  • Chapter
Treating Tumors that Move with Respiration

  • 1078 Accesses

Abstract

Lung cancer is the most common cause of cancer death [1]. While advanced disease portends a very poor prognosis, the subset of patients who present with localized disease are potentially curable. Anatomic lobectomy is the current standard of care for early stage lung cancer [2]. Sub-lobar resection is generally reserved for patients with inadequate pulmonary reserve. For patients with small tumors (2 cm or less) new data suggests that sub-lobar resection may be adequate [3, 4]. It has also become apparent that patients with very marginal pulmonary reserve may safely tolerate lung resection or even have improved pulmonary function afterwards [5, 6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.

    Article  PubMed  Google Scholar 

  2. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615–622; discussion 622–613.

    Article  PubMed  CAS  Google Scholar 

  3. Okada M, Nishio W, Sakamoto T, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005;129:87–93.

    Article  PubMed  Google Scholar 

  4. Yoshikawa K, Tsubota N, Kodama K, et al. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg 2002;73:1055–1058; discussion 1058–1059.

    Article  PubMed  Google Scholar 

  5. Korst RJ, Ginsberg RJ, Ailawadi M, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg 1998;66:898–902.

    Article  PubMed  CAS  Google Scholar 

  6. Choong CK, Meyers BF, Battafarano RJ, et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg 2004;127:1323–1331.

    Article  PubMed  Google Scholar 

  7. Chen M, Hayman JA, Ten Haken RK, et al. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T 1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 2006;64:120–126.

    Article  PubMed  Google Scholar 

  8. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1–11.

    Article  PubMed  Google Scholar 

  9. Graham MV, Pajak TE, Herskovic AM, et al. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results. Int J Radiat Oncol Biol Phys 1995;31:819–825.

    Article  PubMed  CAS  Google Scholar 

  10. Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517–523.

    PubMed  CAS  Google Scholar 

  11. Wigren T, Kellokumpu-Lehtinen P, Ojala A. Radical radiotherapy of inoperable non-small cell lung cancer. Irradiation techniques and tumor characteristics in relation to local control and survival. Acta Oncol 1992;31:555–561.

    PubMed  CAS  Google Scholar 

  12. Dosoretz DE, Galmarini D, Rubenstein JH, et al. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507–516.

    PubMed  CAS  Google Scholar 

  13. Jeremic B, Classen J, Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;54:119–130.

    Article  PubMed  Google Scholar 

  14. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010–1015.

    Article  PubMed  Google Scholar 

  15. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–1431.

    Article  PubMed  Google Scholar 

  16. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623–1631.

    Article  PubMed  Google Scholar 

  17. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946–1955.

    Article  PubMed  Google Scholar 

  18. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83–87.

    Article  PubMed  Google Scholar 

  19. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107–114.

    Article  PubMed  Google Scholar 

  20. Le Q-T, Loo BW, Ho A, et al. Results of a phase I doseescalation study using single-fraction stereotactic radiotherapy for lung tumors. Journal of Thoracic Oncology · Volume, Number, 2006;1:802–809.

    PubMed  Google Scholar 

  21. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833–4839.

    Article  PubMed  Google Scholar 

  22. Handy JR, Jr., Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21–30.

    Article  PubMed  Google Scholar 

  23. McKenna RJ, Jr., Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006;81:421–425; discussion 425–426.

    Article  PubMed  Google Scholar 

  24. Harada H, Okada M, Sakamoto T, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 2005;80:2041–2045.

    Article  PubMed  Google Scholar 

  25. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) nonsmall-cell lung cancer. J Thorac Cardiovasc Surg 1997;113:691–698; discussion 698–700.

    Article  PubMed  CAS  Google Scholar 

  26. Elsherif A, Fernando H, Santos R, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Society of Surgical Oncology; in press.

    Google Scholar 

  27. Birdas TJ, Koehler RP, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Ann Thorac Surg 2006;81:434–438; discussion 438–439.

    Article  PubMed  Google Scholar 

  28. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;129:261–267.

    Article  PubMed  Google Scholar 

  29. Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71:956–960; discussion 961.

    Article  PubMed  CAS  Google Scholar 

  30. Bando T, Yamagihara K, Ohtake Y, et al. A new method of segmental resection for primary lung cancer: intermediate results. Eur J Cardiothorac Surg 2002;21:894–899; discussion 900.

    Article  PubMed  CAS  Google Scholar 

  31. Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 2006;131:988–993.

    Article  PubMed  Google Scholar 

  32. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059–2073.

    Article  PubMed  Google Scholar 

  33. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075–1083.

    Google Scholar 

  34. Firat S, Bousamra M, Gore E, et al. Comorbidity and KPS are independent prognostic factors in stage I nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:1047–1057.

    Article  PubMed  Google Scholar 

  35. Port JL, Kent M, Korst RJ, et al. Surgical resection for lung cancer in the octogenarian. Chest 2004;126:733–738.

    Article  PubMed  Google Scholar 

  36. Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237–245.

    Article  PubMed  Google Scholar 

  37. Onaitis MW, Petersen RP, Balderson SS, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006;244:420–425.

    PubMed  Google Scholar 

  38. McGarry RC, Song G, des Rosiers P, et al. Observationonly management of early stage, medically inoperable lung cancer: poor outcome. Chest 2002;121:1155–1158.

    Article  PubMed  Google Scholar 

  39. Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2002;52:49–57.

    Article  PubMed  Google Scholar 

  40. Alberts WM. The future and lung cancer: room for optimism? Cancer Control 2000;7:13–14.

    PubMed  CAS  Google Scholar 

  41. Baumann M, Appold S, Petersen C, et al. Dose and fractionation concepts in the primary radiotherapy of nonsmall cell lung cancer. Lung Cancer 2001;33Suppl 1: S35–45.

    Article  PubMed  Google Scholar 

  42. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002;35:103–109.

    Article  PubMed  Google Scholar 

  43. Byhardt RW, Martin L, Pajak TF, et al. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) — analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 1993;27:537–544.

    PubMed  CAS  Google Scholar 

  44. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318–328.

    Article  PubMed  Google Scholar 

  45. Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006;65:1075–1086.

    Article  PubMed  Google Scholar 

  46. Lagerwaard FJ, Senan S, van Meerbeeck JP, et al. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 2002;63:151–157.

    Article  PubMed  Google Scholar 

  47. Giraud P, De Rycke Y, Dubray B, et al. Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys 2001;51:1081–1092.

    Article  PubMed  CAS  Google Scholar 

  48. Shimizu S, Shirato H, Ogura S, et al. Detection of lung tumor movement in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:304–310.

    Article  PubMed  CAS  Google Scholar 

  49. Engelsman M, Sharp GC, Bortfeld T, et al. How much margin reduction is possible through gating or breath hold? Phys Med Biol 2005;50:477–490.

    Article  PubMed  CAS  Google Scholar 

  50. Mah D, Hanley J, Rosenzweig KE, et al. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. Int J Radiat Oncol Biol Phys 2000;48:1175–1185.

    Article  PubMed  CAS  Google Scholar 

  51. Keall PJ, Kini VR, Vedam SS, et al. Potential radiotherapy improvements with respiratory gating. Australas Phys Eng Sci Med 2002;25:1–6.

    Article  PubMed  CAS  Google Scholar 

  52. Tada T, Minakuchi K, Fujioka T, et al. Lung cancer: intermittent irradiation synchronized with respiratory motion-results of a pilot study. Radiology 1998;207:779–783.

    PubMed  CAS  Google Scholar 

  53. Willoughby TR, Forbes AR, Buchholz D, et al. Evaluation of an infrared camera and X-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy. Int J Radiat Oncol Biol Phys 2006;66:568–575.

    PubMed  Google Scholar 

  54. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002;52:1041–1046.

    Article  PubMed  Google Scholar 

  55. Harada T, Shirato H, Ogura S, et al. Real-time tumortracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer 2002;95:1720–1727.

    Article  PubMed  Google Scholar 

  56. Blomgren H, Lax I, Göranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method Journal of Radiosurgery 1998;1:63–74.

    Article  Google Scholar 

  57. Reichner CA, Collins BT, Gagnon GJ, et al. The placement of gold fiducials for CyberKnife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. Journal of Bronchology 2005;12:193–195.

    Article  Google Scholar 

  58. Krol AD, Aussems P, Noordijk EM, et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996;34:297–302.

    Article  PubMed  CAS  Google Scholar 

  59. Williams TE, Thomas CR, Jr., Turrisi AT, 3rd. Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 2000;10:315–323.

    Article  PubMed  CAS  Google Scholar 

  60. Robertson JM, Ten Haken RK, Hazuka MB, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079–1085.

    Article  PubMed  CAS  Google Scholar 

  61. Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 1996;41:41–44.

    PubMed  CAS  Google Scholar 

  62. Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48:1015–1024.

    Article  PubMed  CAS  Google Scholar 

  63. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002;63:159–163.

    Article  PubMed  Google Scholar 

  64. Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. Int J Clin Oncol 2004;9:352–355.

    Article  PubMed  Google Scholar 

  65. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—mature results for medically inoperable patients. Lung Cancer 2006;51:97–103.

    Article  PubMed  Google Scholar 

  66. Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg 2003;75:1097–1101.

    Article  PubMed  Google Scholar 

  67. Berger B, Wood R, Fiedler J, et al. Initial Report of CyberKnife Radiosurgery for Non-Surgical Lung Tumors. CyberKnife Society Users’ Meeting. Carlsbad, CA; 2006.

    Google Scholar 

  68. Collins BT, Collins SP, Erickson K, et al. CyberKnife® Frameless Image-guided Fractionated High-dose Stereotactic Radiosurgery with the Synchronyℳ Motion Tracking Module in the Treatment of Small Peripheral Lung Tumors. CyberKnife Society Users’ Meeting. Carlsbad, CA; 2006.

    Google Scholar 

  69. Bellairs E, Fink A, Palmer M, et al. Extracranial Radiosurgery for Lung Tumors. CyberKnife Society Users’ Meeting. Carlsbad, CA; 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heart Lung Esophageal Surgery Institute, University of Pittsburgh Medical Center, 5200 Centre Avenue #715, Pittsburgh, PA, 15232, USA

    Neil A. Christie MD (Assistant Professor)

  2. Department of Radiation Oncology, University of Pittsburgh Medical Center, 5200 Centre Avenue #715, Pittsburgh, PA, 15232, USA

    Steven Burton MD (Assistant Professor)

  3. Heart Lung Esophageal Surg Inst, University of Pittsburg Medical Center, PUH C-800 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    Arjun Pennathur MD (Assistant Professor)

  4. The Heart, Lung & Esophageal Surgery Institute, University of Pittsburgh Medical Center, PUH, C-800 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    James D. Luketich MD (Sampson Family Endowed Professor of Surgery Chief)

Authors
  1. Neil A. Christie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven Burton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arjun Pennathur MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James D. Luketich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research, Education and Clinical Excellence, Baylor University Medical Center, 1201 Barnett Tower 3600 Gaston Avenue, Dallas, TX, 75246, USA

    Harold C. Urschel Jr. MD (Chair of Cardiovascular and Thoracic Surgical) (Chair of Cardiovascular and Thoracic Surgical)

  2. Arizona Oncology Services at St. Joseph’s Hospital & Medical Center Department of Radiation Oncology CyberKnife Center Barrow Neurological Institute, Gamma Knife Center, 350 West Thomas Road, Phoenix, Arizona, 85013, USA

    John J. Kresl MD, PhD

  3. The Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, PUH, C-800, 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    James D. Luketich MD (Sampson Family Endowed Professor of Surgery Chief) (Sampson Family Endowed Professor of Surgery Chief)

  4. Department of Radiation Oncology, University of Texas Southwestern Medical Center, 5801 Forest Park Road, Dallas, TX, 75390, USA

    Lech Papiez PhD (Associate Professor) & Robert D. Timmerman MD (Professor and Vice-Chairman Effie Marie Cain Distinguished Chair in Cancer Therapy Research) (Associate Professor) &  (Professor and Vice-Chairman Effie Marie Cain Distinguished Chair in Cancer Therapy Research)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Christie, N.A., Burton, S., Pennathur, A., Luketich, J.D. (2007). Stereotactic Radiosurgery for Early Stage Non-Small Cell Lung Cancer: Rationale, Patient Selection, Results and Complications. In: Urschel, H.C., Kresl, J.J., Luketich, J.D., Papiez, L., Timmerman, R.D., Schulz, R.A. (eds) Treating Tumors that Move with Respiration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69886-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69886-9_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69885-2

  • Online ISBN: 978-3-540-69886-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation